Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions:   Aneurysm;   Behcet Syndrome, Vascular Type Interventions:   Drug: tocilizumab;   Drug: tofacitinib;   Drug: cyclophosphamide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials

Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions:   Metastatic Breast Cancer;   Triple Negative Breast Cancer;   Estrogen-receptor-low Breast Cancer Interventions:   Drug: Carboplatin;   Drug: Tocilizumab Sponsors:   Kathy Miller;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials

Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions:   Aneurysm;   Behcet Syndrome, Vascular Type Interventions:   Drug: tocilizumab;   Drug: tofacitinib;   Drug: cyclophosphamide Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials

A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus
Condition:   Systemic Lupus Erythematosus Interventions:   Drug: RO7507062;   Drug: Tocilizumab Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials

A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
Conditions:   Mantle Cell Lymphoma;   Mantle Cell Lymphoma Refractory Interventions:   Drug: Glofitamab;   Drug: Pirtobrutinib;   Drug: Obinutuzumab;   Drug: Tocilizumab Sponsor:   Australasian Leukaemia and Lymphoma Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials